Author

A. Ardaseva

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Organism:human· 1

Frequent Co-Authors

A. R. A. Anderson· 1 shared C. Harmon· 1 shared D. Maestrini· 1 shared D. Park· 1 shared D. Williamson· 1 shared H. Khong· 1 shared H. M. Byrne· 1 shared J. West· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. R. A. Anderson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A mathematical dissection of the adaptation of cell populations to fluctuating oxygen levels

A. Ardaseva, R. A. Gatenby, A. R. A. Anderson, H. M. Byrne, P. K. Maini, T. Lorenzi

The paper uses a phenotype-structured model to show how fluctuating oxygen levels affect cell population dynamics and competitive advantage through phenotypic variation rates.

bioRxiv · Mar 9, 2020Cancer Biology

Evolutionary exploitation of PD-L1 expression in hormone receptor positive breast cancer

J. West, D. Park, C. Harmon, D. Williamson, P. Ashcroft, D. Maestrini, A. Ardaseva, R. Bravo, P. Sahoo, H. Khong, K. Luddy, M. Robertson-Tessi

The paper models how timing of aromatase inhibitor and immune checkpoint inhibitor therapies affects tumor burden and metastatic potential in hormone receptor positive breast cancer.

bioRxiv · Oct 26, 2018 · PreprintCancer Biology